sponsored byAAAS Golden Fund

Username:

Password:

Register

Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books

Meetings

Multimedia

Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation

Calendar

Submit a Calendar Item

Subscribe/Sponsor

Links & Resources

Portals

RSS Feeds

Accessibility Option On

Options

Portal Home

Glossary

Background Articles

Research Papers

Meetings

Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 101-125 out of 1344.

<< < 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 > >>

Public Release: 10-Apr-2017
DesignMedix's malaria drug to enter clinical trials with support from NIH
DesignMedix Inc., a drug development company targeting drug resistant infectious diseases, has entered into an agreement with the National Institutes of Health that will pave the way for first-in-human clinical trials of DesignMedix's malaria drug DM1157.

Contact: Sandra Shotwell
shotwell@designmedix.com
503-348-0855
Portland State University

Public Release: 10-Apr-2017
Nature Medicine
The first live-attenuated vaccine candidate completely protects against Zika infection
The first live-attenuated Zika vaccine still in the development stage completely protected mice against the virus after a single vaccination dose, according to new research from the University of Texas Medical Branch at Galveston and Instituto Evandro Chagas at the Ministry of Health in Brazil. The findings are currently available in Nature Medicine.

Contact: Donna Ramirez
donna.ramirez@utmb.edu
409-772-8791
University of Texas Medical Branch at Galveston

Public Release: 10-Apr-2017
Nature Communications
Researchers gain insight into protein critical to Zika virus reproduction
Berkeley Lab researchers collaborated with colleagues from the University of Indiana and Texas A&M University to solve the atomic structure of a Zika virus protein that is key to viral reproduction. The X-ray studies were conducted at the Advanced Light Source in the Berkeley Center for Structural Biology.
National Institutes of Health, Howard Hughes Medical Institute

Contact: Jon Weiner
jrweiner@lbl.gov
510-486-4014
DOE/Lawrence Berkeley National Laboratory

Public Release: 10-Apr-2017
Proceedings of the National Academy of Sciences
Vaccines save lives, but maintaining widespread coverage is essential
Emory Vaccine Center leaders emphasize vaccines' life-saving and economic benefits along with importance of community confidence in vaccination.

Contact: Holly Korschun
hkorsch@emory.edu
404-727-3990
Emory Health Sciences

Public Release: 10-Apr-2017
Proceedings of the National Academy of Sciences
El Nino shifts geographic distribution of cholera cases in Africa
Cholera cases in East Africa increase by roughly 50,000 during El Niño, the cyclical weather occurrence that profoundly changes global weather patterns, new Johns Hopkins Bloomberg School of Public Health research suggests.
Bill and Melinda Gates Foundation, National Science Foundation

Contact: Stephanie Desmon
sdesmon1@jhu.edu
410-955-7619
Johns Hopkins University Bloomberg School of Public Health

Public Release: 10-Apr-2017
American Journal of Tropical Medicine and Hygiene
Mysterious outbreak of disfiguring tropical disease in western Uganda linked to decades of walking barefoot in volcanic soils
A puzzling surge in western Uganda patients diagnosed with a painful, disfiguring skin condition known as elephantiasis was caused not by the parasitic worms typically associated with the affliction, but by long-term exposure to irritating soil minerals absorbed while walking barefoot, according to a new study published today in the American Journal of Tropical Medicine and Hygiene.

Contact: Bridget DeSimone
bdesimone@burness.com
301-280-5735
Burness

Public Release: 9-Apr-2017
Proceedings of the National Academy of Sciences
Programmed proteins might help prevent malaria
A new approach to stabilizing protein structures could be key to an efficient vaccine.

Contact: Gizel Maimon
gizel.maimon@weizmann.ac.il
972-893-43856
Weizmann Institute of Science

Public Release: 8-Apr-2017
EuroPrevent 2017
Grey hair linked with increased heart disease risk in men
Grey hair has been linked with an increased risk of heart disease in men, in research presented today at EuroPrevent 2017.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 8-Apr-2017
EuroPrevent 2017
Obese Spanish workers take more sick leave
Obese Spanish workers take more sick leave than their healthy weight colleagues, according to research in more than 174,000 employees presented today at EuroPrevent 2017.
Carlos III Health Institute, Spain, and the European Regional Development Fund

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 7-Apr-2017
Grant to support research aimed at benefitting patients with IBD
Inflammatory bowel disease is a chronic inflammatory disease of the intestine that includes Crohn's disease and ulcerative colitis. A protective protein that plays a key role in IBD is TCPTP. Declan McCole, associate professor of biomedical sciences in the School of Medicine at the University of California, Riverside, has received a two-year grant of $150,000 from Pfizer Inc. to explore a therapeutic target for correcting intestinal barrier defects in IBD patients who have TCPTP mutations.
Pfizer Inc.

Contact: Iqbal Pittalwala
iqbal@ucr.edu
951-827-6050
University of California - Riverside

Public Release: 7-Apr-2017
EuroPrevent 2017
Big women have nearly threefold greater risk of atrial fibrillation
Big women have a nearly threefold greater risk of atrial fibrillation than small women, according to research presented today at EuroPrevent 2017. The study included 1.5 million women who were followed-up for more than 30 years.
Swedish Government, Swedish Heart and Lung Foundation, and others

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 6-Apr-2017
Ebola: New trial launched in west Africa to evaluate three vaccination strategies
The French National Institute of Health and Medical Research (Inserm), the US National Institutes of Health (NIH) and the London School of Hygiene & Tropical Medicine (LSHTM), in collaboration with health authorities in Guinea and Liberia, are launching a large clinical trial of candidate Ebola vaccines under the aegis of the PREVAC international consortium (Partnership for Research on Ebola VACcination).
The French National Institute of Health, Medical Research, London School of Hygiene & Tropical Medicine, NIH/National Institute of Allergy and Infectious Diseases

Contact: NIAID Office of Communications
niaidnews@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases

Public Release: 6-Apr-2017
Molecular Cell
Rutgers researchers determine structure of tuberculosis drug target
Rutgers University scientists have determined the three-dimensional structure of the target of the first-line anti-tuberculosis drug rifampin. They have also discovered a new class of potential anti-tuberculosis drugs that kill rifampin-resistant and multi-drug-resistant tuberculosis bacteria. Tuberculosis (TB) bacteria infect a third of the world's population and the disease kills 1.8 million people annually.
NIH/National Institute of General Medical Sciences, NIH/National Institute of Allergy and Infectious Diseases, Global Alliance for TB Drug Development

Contact: Todd B. Bates
tbates@ucm.rutgers.edu
848-932-0550
Rutgers University

Public Release: 5-Apr-2017
Science Translational Medicine
Researchers develop Marburg virus treatment effective five days after infection
An antibody treatment successfully protected nonhuman primates against the deadly Marburg and Ravn viruses even when given five days after becoming infected, according to the latest findings of a collaborative team from The University of Texas Medical Branch at Galveston, Mapp Biopharmaceutical Inc., and Vanderbilt University.

Contact: Donna Ramirez
donna.ramirez@utmb.edu
409-772-8791
University of Texas Medical Branch at Galveston

Public Release: 5-Apr-2017
Science Translational Medicine
Monoclonal antibody cures Marburg infection in monkeys
Scientists funded by the National Institutes of Health have found that an experimental treatment cured 100 percent of guinea pigs and rhesus monkeys in late stages of infection with lethal levels of Marburg and Ravn viruses, relatives of the Ebola virus. Although the Marburg and Ravn viruses are less familiar than Ebola virus, both can resemble Ebola in symptoms and outcomes in people, and both lack preventive and therapeutic countermeasures.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Ken Pekoc
kpekoc@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases

Public Release: 5-Apr-2017
BMC Health Services Research
Curbing alcohol to fight HIV could save money in Kenya
Expanding a program in Kenya that fights the spread of HIV by curbing alcohol consumption could produce a net economic benefit, a new study projects.
National Institutes of Health

Contact: David Orenstein
david_orenstein@brown.edu
401-863-1862
Brown University

Public Release: 5-Apr-2017
American Chemical Society 253rd National Meeting & Exposition
Addictive nut's derivatives could help smokers break the nicotine habit
As many as 600 million people in Asia chew areca nuts with betel leaves, sometimes adding tobacco leaves. Many users are addicted to this harmful preparation, which can create a sense of euphoria. Yet researchers have now discovered that compounds derived from the nut could help cigarette smokers -- as well as betel quid chewers -- kick their habits. They present their work today at the 253rd National Meeting & Exposition of the American Chemical Society.

Contact: Katie Cottingham
k_cottingham@acs.org
301-775-8455
American Chemical Society

Public Release: 4-Apr-2017
Science
Pre-existing immunity to dengue and West Nile may cause increased risk in Zika-infected
As the Zika virus continues to spread rapidly across the globe, it might pose a particular risk to people previously infected with two related viruses, dengue and West Nile, researchers at the Icahn School of Medicine at Mount Sinai have found. Their study, published in the journal Science, may help explain the severe manifestations of Zika virus infection observed in specific populations, including those in South America.

Contact: Lucia Lee
newsmedia@mssm.edu
212-241-9200
The Mount Sinai Hospital / Mount Sinai School of Medicine

Public Release: 4-Apr-2017
KU Leuven to lead development of dual vaccine against yellow fever and rabies
Rabies and yellow fever claim ten thousands of lives each year. Vaccines already exist but various drawbacks that hinder their efficient distribution. One of them is the need to transport and store these vaccines at cool temperatures. The RABYD-VAX consortium, led by KU Leuven (University of Leuven, Belgium), has now started developing a cheap, temperature-stable, and easy-to-produce vaccine against both diseases at once.
European Union's Horizon 2020 Research and Innovation Programme

Contact: Johan Neyts
johan.neyts@kuleuven.be
32-163-21893
KU Leuven

Public Release: 4-Apr-2017
mBio
MERS-like coronavirus identified in Ugandan bat
A team of researchers in the United States and Uganda has identified a novel coronavirus in a bat from Uganda that is similar to the one causing Middle East Respiratory Syndrome (MERS) in people, giving further credence to the theory that such viruses originate in bats. The work was described this week in mBio®, an online open-access journal of the American Society for Microbiology.
United States Agency for International Development Emerging Pandemic Threats PREDICT project, NIH/National Institutes of Allergy and Infectious Disease, NIH/National Institute of Diabetes and Digestive and Kidney Diseases

Contact: Tim Paul
tp2111@columbia.edu
212-305-2676
Columbia University's Mailman School of Public Health

Public Release: 31-Mar-2017
University of Miami to begin phase 2 Zika vaccine trial
The University of Miami Miller School of Medicine will soon begin one of the nation's first full-scale Zika vaccine clinical trials testing the National Institutes of Health's (NIH) experimental DNA-based vaccine. As Miami-Dade County has been ground zero for the Zika virus outbreak in the U.S., testing the vaccine in an endemic region is critical to help determine the vaccine's safety, effective dosage and whether it can effectively prevent disease caused by Zika infection.
NIH/National Institute of Allergy and Infectious

Contact: Kai Hill
khill@miami.edu
305-243-3249
University of Miami

Public Release: 31-Mar-2017
European Journal of Preventive Cardiology
Insomnia associated with increased risk of heart attack and stroke
Insomnia is associated with increased risk of heart attack and stroke, according to research published today in the European Journal of Preventive Cardiology.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 30-Mar-2017
Annals of Neurology
The US burden of neurological disease is nearly $800 billion/year
The most common neurological diseases cost the United States $789 billion in 2014, and this figure is projected to grow as the elderly population doubles between 2011 and 2050, according to a new study published in the April issue of the Annals of Neurology.

Contact: Dawn Peters & Tracy Simon
tsimon@steegethomson.com
781-388-8408
Wiley

Public Release: 29-Mar-2017
Vaccine
Global immunization impact constrained by outdated vaccine delivery systems, researchers say
Outdated vaccine supply and distribution systems are delaying and limiting the impact that vaccines have on safeguarding people's health. Among the challenges of ensuring a consistent supply of potent vaccines identified by researchers: one in every three countries in the world experiences at least one stockout of at least one vaccine for at least one month; and 19 to 38 percent of vaccines worldwide are accidentally exposed to freezing temperatures, potentially compromising the potency of those vaccines.

Contact: Preeti Singh
psingh@burness.com
301-280-5722
Burness

Public Release: 28-Mar-2017
PLOS Neglected Tropical Diseases
Wealth and knowledge drive bushmeat consumption during the West African Ebola crisis
Bushmeat, or wild animal meat, is an essential source of protein for many people in tropical regions. But handling and eating bushmeat carries the risk of contracting diseases, such as Ebola virus disease (EVD). During the latest and largest ever recorded Ebola crisis, household income and specific knowledge about the risks of eating bushmeat were linked to changes in its consumption, researchers report in PLOS Neglected Tropical Diseases. Although bushmeat consumption in Liberia generally decreased during the crisis, preferences for bushmeat remained constant.

Contact: PLOS Neglected Tropical Diseases
plosntds@plos.org
PLOS

Showing releases 101-125 out of 1344.

<< < 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 > >>